SEC Form 3 · accession 0001250853-18-000104
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bret Hankey
Director
Period of report
Jul 31, 2017
Accepted (ET)
Jul 25, 2018 · 7:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 28,034 | D | ||
| Common StockF1,F2 | holding | — | — | — | 5,004,058 | I | By Hankey Capital, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The share numbers reflect a reverse split of 1:10 effected on July 16, 2018.
- F2Consists of shares held by Hankey Capital, LLC ("HC"); of the 5,004,298 shares held by HC, 1,139,240 shares are collateral for the repayment of convertible notes ("Notes") that will only become the property of HC pursuant to its rights as a secured lender, in the Event of a Default under the Notes. HC is owned by Hankey Investment Company LP ("HIC") of which the Bret Hankey Trust ("Bret Trust") owns a 5.83% interest, the Rufus and Bret Hankey Trust ("RB Trust") owns a 0.94% interest and the Hankey Children's Trust ("Children's Trust") owns a 0.99% interest. Mr. Hankey is the settlor and trustee of the Bret Trust and Mr. Hankey's immediate family are beneficiaries of the Bret Trust; Mr. Hankey is one of the settlors of the RB Trust, of which, the Bret Trust is one of the beneficiaries and Mr. Hankey is a successor trustee of the Children's Trust. Mr. Hankey disclaims beneficial ownership in the shares held by HC except to the extent of his or his immediate family's pecuniary interest.